Immuno-PET for Clinical Theranostic Approaches

@inproceedings{Bailly2016ImmunoPETFC,
  title={Immuno-PET for Clinical Theranostic Approaches},
  author={Cl{\'e}ment Bailly and Pierre-François Cl{\'e}ry and Alain Faivre-Chauvet and Mickael Bourgeois and François Gu{\'e}rard and Ferid Haddad and Jacques Barbet and Michel Ch{\'e}rel and Françoise Kraeber-Bod{\'e}r{\'e} and Thomas Carlier and Caroline Bodet-Milin},
  booktitle={International journal of molecular sciences},
  year={2016}
}
Recent advances in molecular characterization of tumors have allowed identification of new molecular targets on tumor cells or biomarkers. In medical practice, the identification of these biomarkers slowly but surely becomes a prerequisite before any treatment decision, leading to the concept of personalized medicine. Immuno-positron emission tomography (PET) fits perfectly with this approach. Indeed, monoclonal antibodies (mAbs) labelled with radionuclides represent promising probes for… CONTINUE READING
2
Twitter Mentions

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

A New Possibility in Fertility Preservation: the Artificial Ovary.

  • Journal of tissue engineering and regenerative medicine
  • 2019
VIEW 2 EXCERPTS
CITES METHODS & BACKGROUND

ImmunoPET imaging of CD38 in murine lymphoma models using 89Zr-labeled daratumumab

  • European Journal of Nuclear Medicine and Molecular Imaging
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 81 REFERENCES

Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients.

  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 2016
VIEW 1 EXCERPT

Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma.

  • Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 2016
VIEW 1 EXCERPT